These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3794210)

  • 1. [Endogenous digitalis-like substances in umbilical cord blood: analytical interference or new hormones?].
    Sandouk P; Scherrmann JM; Barrier J; Ciraru-Vigneron N; Guedeney X; Bourdon R
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):737-42. PubMed ID: 3794210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Digitalis receptor].
    Rey HG; Anner BM
    Schweiz Med Wochenschr; 1987 Nov; 117(48):1881-7. PubMed ID: 2827301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endogenous digoxin-like substance (nonspecific interference or a new hormone?)].
    Kovács L; Lichardus B; Bircák J; Benetínová J; Ponecová M; Masurová A; Stefaníková J
    Cesk Pediatr; 1989 Feb; 44(2):73-5. PubMed ID: 2720827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of endogenous digitalis-like factor(s) from cord blood of neonate by immunoaffinity chromatography.
    Montali U; Balzan S; Ghione S
    Biochem Int; 1991 Dec; 25(5):853-9. PubMed ID: 1804104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors of importance for valid digitalis assays particularly for the determination of digoxin in plasma and urine.
    Molin L
    Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 4():1-62. PubMed ID: 3739734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous digitalis-like immunoreactive substances in cord serum characterized by anti-digitoxin and anti-digoxin antibodies. Effect of modulated incubation conditions.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Biochem; 1986 Aug; 19(4):201-4. PubMed ID: 3530526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous glycosides in critically ill patients.
    Berendes E; Cullen P; Van Aken H; Zidek W; Erren M; Hübschen M; Weber T; Wirtz S; Tepel M; Walter M
    Crit Care Med; 2003 May; 31(5):1331-7. PubMed ID: 12771599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digitalis, digitalis antibodies, digitalis-like immunoreactive substances, and sodium homeostasis: a review.
    Hastreiter AR; John EG; van der Horst RL
    Clin Perinatol; 1988 Sep; 15(3):491-522. PubMed ID: 3066550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of elevated postmortem serum concentrations of digoxin in infants and children.
    Koren G; Beatie D; Soldin S; Einerson TR; MacLeod S
    Arch Pathol Lab Med; 1989 Jul; 113(7):758-61. PubMed ID: 2742457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
    Li J; Wu Z; Xu J; Zhou Y; Chu X
    Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy.
    Graves SW; Lincoln K; Cook SL; Seely EW
    Am J Hypertens; 1995 Jan; 8(1):5-11. PubMed ID: 7734097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex, digitalis, and the sodium pump.
    Blaustein MP; Robinson SW; Gottlieb SS; Balke CW; Hamlyn JM
    Mol Interv; 2003 Mar; 3(2):68-72, 50. PubMed ID: 14993426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The source of endogenous digitalis-like substance in normal pregnancy].
    Gao S; Chen Z; Xu Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):539-41. PubMed ID: 10806730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like substance in term pregnancy, newborns, and renal failure.
    Witherspoon L; Shuler S; Alyea K; Figueroa J; Neely H
    J Nucl Med; 1986 Sep; 27(9):1418-22. PubMed ID: 3746444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous digoxin-immunoreactive substance measured in several patient populations.
    Valdes R
    Prog Clin Biol Res; 1985; 192():221-8. PubMed ID: 4080710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the probability of digitalis toxicity using a combination of clinical criteria and blood digoxin levels].
    de Abajo FJ; Frías J
    Med Clin (Barc); 1991 Jun; 97(2):77-8. PubMed ID: 1895792
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous digoxin-like immunoreactivity during pregnancy and at birth.
    Lupoglazoff JM; Jacqz-Aigrain E; Guyot B; Chappey O; Blot P
    Br J Clin Pharmacol; 1993 Mar; 35(3):251-4. PubMed ID: 8471401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-like immunoreactive substance in postmortem blood of infants and children.
    Spiehler VR; Fischer WR; Richards RG
    J Forensic Sci; 1985 Jan; 30(1):86-91. PubMed ID: 3981124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.